Health Empire Corporation Public Company Limited - Equity Warrant - Laporan Laba Rugi (TTM)

Health Empire Corporation Public Company Limited - Equity Warrant
TH ˙ SET
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Health Empire Corporation Public Company Limited - Equity Warrant menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 122 109 84 100 94 124 150 164 167 118 86 46 31 25 26 29 37 46 64 83
Change (%) -10.90 -23.28 20.12 -6.49 32.48 20.60 9.11 1.92 -29.24 -26.80 -46.21 -34.26 -17.96 3.93 12.71 26.37 23.46 39.34 29.87
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 79 71 47 55 45 51 69 74 78 60 40 20 12 10 11 13 18 22 34 42
Change (%) -10.41 -34.31 18.03 -19.11 13.76 35.96 6.83 5.39 -22.20 -34.49 -49.25 -39.10 -20.03 11.42 20.22 34.67 27.20 51.56 24.69
% of Revenue 64.94 65.29 55.91 54.93 47.52 40.81 46.00 45.04 46.58 51.21 45.82 43.23 40.05 39.04 41.85 44.64 47.57 49.01 53.31 51.18
Gross Operating Profit 43 38 37 45 49 74 81 90 89 58 47 26 18 15 15 16 19 23 30 40
Change (%) -11.80 -2.53 22.77 8.88 49.44 10.01 11.05 -0.92 -35.37 -18.72 -43.63 -30.57 -16.58 -0.87 7.31 19.69 20.07 27.60 35.80
% of Revenue 35.06 34.71 44.09 45.07 52.48 59.19 54.00 54.96 53.42 48.79 54.18 56.77 59.95 60.96 58.15 55.36 52.43 50.99 46.69 48.82
SG&A 67 65 67 78 86 133 157 183 180 139 108 73 67 77 79 89 87 63 59 52
Change (%) -2.86 3.77 15.07 10.33 55.95 17.69 16.42 -1.42 -23.14 -21.84 -32.34 -8.54 14.28 3.15 12.53 -1.89 -27.60 -6.69 -12.23
% of Revenue 54.68 59.61 80.63 77.24 91.13 107.28 104.69 111.71 108.04 117.35 125.30 157.60 219.27 305.45 303.17 302.69 234.99 137.81 92.29 62.36
R&D
Change (%)
% of Revenue
OpEx 146 136 114 133 130 184 226 257 258 199 148 93 79 86 90 102 105 86 93 94
Change (%) -6.96 -16.13 16.28 -1.90 41.49 22.73 13.49 0.54 -22.86 -25.69 -36.87 -15.12 8.98 4.09 13.46 2.81 -18.37 8.59 1.28
% of Revenue 119.62 124.90 136.53 132.17 138.66 148.08 150.69 156.75 154.62 168.56 171.12 200.83 259.32 344.49 345.02 347.33 282.56 186.82 145.59 113.54
Operating Income -24 -27 -31 -32 -36 -60 -76 -93 -91 -81 -61 -47 -49 -61 -64 -73 -68 -40 -29 -11
Change (%) 13.12 12.56 5.78 12.36 64.78 27.15 22.14 -1.91 -11.18 -24.06 -23.73 3.87 25.90 4.15 13.77 -6.72 -41.29 -26.82 -61.42
% of Revenue -19.62 -24.90 -36.53 -32.17 -38.66 -48.08 -50.69 -56.75 -54.62 -68.56 -71.12 -100.83 -159.32 -244.49 -245.02 -247.33 -182.56 -86.82 -45.59 -13.54
Interest Expense -1 -1 -1 -1 -2 -2 -2 -3 -3 -2 -2 -2 -2 -2 -2 -2 -1 -1 -1 -1
Change (%) 15.85 0.38 -7.46 26.27 13.10 17.11 23.21 -1.16 -12.12 -1.76 1.36 -7.29 13.56 -11.88 -20.01 -17.63 -34.99 -11.32 10.84
% of Revenue -1.01 -1.31 -1.71 -1.32 -1.78 -1.52 -1.48 -1.67 -1.62 -2.01 -2.70 -5.09 -7.17 -9.93 -8.42 -5.98 -3.90 -2.05 -1.31 -1.11
Net Income -25 -28 -30 -29 -34 -45 -51 -44 -33 -457 -445 -469 -478 -264 -270 -498 -493 -458 -447 -204
Change (%) 12.50 7.03 -4.94 18.52 32.16 13.89 -14.93 -25.45 1,300.27 -2.58 5.29 1.97 -44.71 1.99 84.71 -0.98 -7.11 -2.47 -54.27
% of Revenue -20.62 -26.04 -36.33 -28.75 -36.44 -36.35 -34.33 -26.77 -19.58 -387.43 -515.61 -1,009.24 -1,565.49 -1,055.14 -1,035.47 -1,696.96 -1,329.66 -1,000.41 -700.22 -246.55

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista